STM:NYSESTMicroelectronics N.V. Analysis
Data as of 2026-03-15 - not real-time
$32.87
Latest Price
8/10Risk
Risk Level: High
Executive Summary
STMicroelectronics is trading above its 20‑day SMA (33.42) but still below the 50‑day SMA (30.85), indicating a short‑term bullish bias, while the MACD histogram remains negative and the signal line is bearish, suggesting caution. Volume is increasing and the RSI sits at a neutral 51, so momentum is not yet decisive. The stock’s price of $32.87 sits near the identified support level of $30.66 and well below the resistance of $34.91, offering a modest upside of about 7% per the DCF‑derived fair value of $25.70. However, the trailing P/E of 182x vastly exceeds the industry average of 34x, and the forward P/E of 17.5x still signals a premium valuation. Dividend sustainability is questionable with a payout ratio of 200%, and free cash flow is negative, raising concerns about cash generation. The broader market sentiment is in “Greed” mode (Fear‑Greed Index 72.9), which can amplify price moves in a high‑beta (≈1.9) semiconductor stock.
Recent product announcements—including an AI‑accelerated automotive microcontroller, silicon‑photonic platforms for AI infrastructure, and ultra‑wideband solutions—position STM to capture growth in the EV and intelligent‑sensing markets. These initiatives could improve top‑line momentum, but revenue growth remains flat at 0.2% and margins are modest, limiting immediate earnings upside. The combination of high volatility (54% 30‑day) and a recent max drawdown of 36% underscores the stock’s risk profile. Investors should weigh the short‑term technical support and bullish volume against the long‑term valuation gap and cash flow constraints.
Recent product announcements—including an AI‑accelerated automotive microcontroller, silicon‑photonic platforms for AI infrastructure, and ultra‑wideband solutions—position STM to capture growth in the EV and intelligent‑sensing markets. These initiatives could improve top‑line momentum, but revenue growth remains flat at 0.2% and margins are modest, limiting immediate earnings upside. The combination of high volatility (54% 30‑day) and a recent max drawdown of 36% underscores the stock’s risk profile. Investors should weigh the short‑term technical support and bullish volume against the long‑term valuation gap and cash flow constraints.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bullish SMA crossover
- Increasing volume and neutral RSI suggest limited upside
- High valuation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- New AI‑enabled automotive microcontroller and silicon photonics drive demand
- EV and intelligent‑sensing market tailwinds
- Improving top‑line visibility despite flat revenue growth
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Persistent overvaluation and high beta increase exposure to market cycles
- Dividend payout ratio unsustainable and free cash flow negative
- Fundamental margins and ROE remain low, limiting long‑term earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth0.20%
Profit Margin1.41%
P/E Ratio182.6
ROE1.00%
ROA1.25%
Debt/Equity12.92
P/B Ratio1.6
Op. Cash Flow$2.2B
Free Cash Flow$-407375008
Industry P/E33.7
Technical Analysis
TrendBullish
RSI51.9
Support$30.66
Resistance$34.91
MA 20$33.42
MA 50$30.85
MA 200$28.02
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$25.70
Target Price$35.22
Upside/Downside7.15%
GradeOvervalued
TypeValue
Dividend Yield1.10%
Risk Assessment
Beta1.92
Volatility54.49%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.